| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.4 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |